Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biochemical and Biophysical Research Communications|September 24, 2004
Membrane permeabilization by non-steroidal anti-inflammatory drugsWataru Tomisato, Ken-ichiro Tanaka, Takashi Katsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in miceKatharina Brandl, Wataru Tomisato, Xiaohong Li, et al.
Biopharmaceutics & Drug Disposition|October 21, 2016
Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysisShin-Ichi Inaba, Maki Goto, Kaoru Tanaka-Takanaka, et al.
Cancer Research|November 27, 2019
The NOTCH-FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory-like CAR-T CellsTaisuke Kondo, Makoto Ando, Nao Nagai, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 AgonistTakahide Nishi, Shojiro Miyazaki, Toshiyasu Takemoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5Duanwu Zhang, Wataru Tomisato, Lijing Su, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2012
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonistTsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, et al.
European Journal of Medicinal Chemistry|March 13, 2012
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonistTsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2012
Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonistsMasayoshi Asano, Tsuyoshi Nakamura, Yukiko Sekiguchi, et al.
BMC Research Notes|October 26, 2012
ENU-induced phenovariance in mice: inferences from 587 mutationsCarrie N Arnold, Michael J Barnes, Michael Berger, et al.
Pageof 3